U.S. Multiomics Market (2025 - 2033) Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                        1.2.1. Product & Service
                        1.2.2. Type
                        1.2.3. Platform
                        1.2.4. Application
                        1.2.5. End Use
                    1.3. Information analysis
                    1.4. Market formulation & data visualization
                    1.5. Data validation & publishing
                    1.6. Information Procurement
                        1.6.1. Primary Research
                    1.7. Information or Data Analysis
                    1.8. Market Formulation & Validation
                    1.9. Market Model
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Technological Innovation
                            3.2.1.2. Advancements in precision medicine
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Data integration and analytical complexity
                            3.2.2.2. High cost of multiomics technologies and workflows
                    3.3. Industry Analysis Tools
                        3.3.1. Porter's Five Forces Analysis
                        3.3.2. PESTEL Analysis
Chapter 4. U.S. Multiomics Market: Product & Service Business Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Multiomics Market Product & Service Movement Analysis
                    4.3. U.S. Multiomics Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
                    4.4. Product
                        4.4.1. Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.4.2. Instruments
                            4.4.2.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.4.3. Consumables
                            4.4.3.1. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.4.4. Software
                            4.4.4.1. Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.5. Services
                        4.5.1. Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Multiomics Market: Type Business Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Multiomics Market Type Movement Analysis
                    5.3. U.S. Multiomics Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
                    5.4. Single-cell Multiomics
                        5.4.1. Single-cell Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.5. Bulk Multiomics
                        5.5.1. Bulk. Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Multiomics Market: Platform Business Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Multiomics Market Platform Movement Analysis
                    6.3. U.S. Multiomics Market Size & Trend Analysis, by Platform, 2021 to 2033 (USD Million)
                    6.4. Genomics
                        6.4.1. Genomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.5. Transcriptomics
                        6.5.1. Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.6. Proteomics
                        6.6.1. Proteomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.7. Metabolomics
                        6.7.1. Metabolomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.8. Integrated Omics Platforms
                        6.8.1. Integrated Omics Platforms Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Multiomics Market: Application Business Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Multiomics Market Application Movement Analysis
                    7.3. U.S. Multiomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    7.4. Cell Biology
                        7.4.1. Cell Biology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.5. Oncology
                        7.5.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.6. Neurology
                        7.6.1. Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.7. Immunology
                        7.7.1. Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. U.S. Multiomics Market: End Use Business Analysis
                    8.1. Segment Dashboard
                    8.2. U.S. Multiomics Market End Use Movement Analysis
                    8.3. U.S. Multiomics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    8.4. Academic and Research Institutes
                        8.4.1. Academic and Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    8.5. Pharmaceutical & Biotechnology Companies
                        8.5.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    8.6. Others
                        8.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Participant Categorization
                    9.2. Strategy Mapping
                    9.3. Company Market Position Analysis, 2024
                    9.4. Participant’s Overview
                        9.4.1. BD
                            9.4.1.1. Overview
                            9.4.1.2. Financial Performance
                            9.4.1.3. Product Benchmarking
                            9.4.1.4. Strategic Initiatives
                        9.4.2. Thermo Fisher Scientific Inc.
                            9.4.2.1. Overview
                            9.4.2.2. Financial Performance
                            9.4.2.3. Product Benchmarking
                            9.4.2.4. Strategic Initiatives
                        9.4.3. Illumina, Inc
                            9.4.3.1. Overview
                            9.4.3.2. Financial Performance
                            9.4.3.3. Product Benchmarking
                            9.4.3.4. Strategic Initiatives
                        9.4.4. Danaher (Beckman Coulter)
                            9.4.4.1. Overview
                            9.4.4.2. Financial Performance
                            9.4.4.3. Product Benchmarking
                            9.4.4.4. Strategic Initiatives
                        9.4.5. PerkinElmer Inc.
                            9.4.5.1. Overview
                            9.4.5.2. Financial Performance
                            9.4.5.3. Product Benchmarking
                            9.4.5.4. Strategic Initiatives
                        9.4.6. Shimadzu Corporation
                            9.4.6.1. Overview
                            9.4.6.2. Financial Performance
                            9.4.6.3. Product Benchmarking
                            9.4.6.4. Strategic Initiatives
                        9.4.7. Bruker
                            9.4.7.1. Overview
                            9.4.7.2. Financial Performance
                            9.4.7.3. Product Benchmarking
                            9.4.7.4. Strategic Initiatives
                        9.4.8. QIAGEN
                            9.4.8.1. Overview
                            9.4.8.2. Financial Performance
                            9.4.8.3. Product Benchmarking
                            9.4.8.4. Strategic Initiatives
                        9.4.9. Agilent Technologies, Inc.
                            9.4.9.1. Overview
                            9.4.9.2. Financial Performance
                            9.4.9.3. Product Benchmarking
                            9.4.9.4. Strategic Initiatives
                        9.4.10. BGI Genomics
                            9.4.10.1. Overview
                            9.4.10.2. Financial Performance
                            9.4.10.3. Product Benchmarking
                            9.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 4 U.S. multiomics market, by type, 2021 - 2033 (USD Million)
Table 5 U.S. multiomics market, by platform, 2021 - 2033 (USD Million)
Table 6 U.S. multiomics market, by application, 2021 - 2033 (USD Million)
Table 7 U.S. multiomics market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Multiomics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook
Fig. 13 U.S. multiomics market driver analysis
Fig. 14 U.S. multiomics market restraint analysis
Fig. 15 U.S. multiomics market: Porter's analysis
Fig. 16 U.S. multiomics market: PESTEL analysis
Fig. 17 U.S. multiomics market: Product & service outlook and key takeaways
Fig. 18 U.S. multiomics market: Product & service market share analysis, 2024 - 2033
Fig. 19 U.S. multiomics by products market, 2021 - 2033 (USD Million)
Fig. 20 U.S. multiomics by instruments market, 2021 - 2033 (USD Million)
Fig. 21 U.S. multiomics by consumables market, 2021 - 2033 (USD Million)
Fig. 22 U.S. multiomics by software market, 2021 - 2033 (USD Million)
Fig. 23 U.S. multiomics by services market, 2021 - 2033 (USD Million)
Fig. 24 U.S. Multiomics market: Type outlook and key takeaways
Fig. 25 U.S. Multiomics market: Type market share analysis, 2024 - 2033
Fig. 26 U.S. multiomics by single-cell multiomics market, 2021 - 2033 (USD Million)
Fig. 27 U.S. multiomics by bulk multiomics market, 2021 - 2033 (USD Million)
Fig. 28 U.S. Multiomics market: Platform outlook and key takeaways
Fig. 29 U.S. Multiomics market: Platform market share analysis, 2024 - 2033
Fig. 30 U.S. multiomics by genomics market, 2021 - 2033 (USD Million)
Fig. 31 U.S. multiomics by transcriptomics market, 2021 - 2033 (USD Million)
Fig. 32 U.S. multiomics by proteomics market, 2021 - 2033 (USD Million)
Fig. 33 U.S. multiomics by metabolomics market, 2021 - 2033 (USD Million)
Fig. 34 U.S. multiomics by integrated omics platforms market, 2021 - 2033 (USD Million)
Fig. 35 U.S. Multiomics market: Application outlook and key takeaways
Fig. 36 U.S. Multiomics market: Application market share analysis, 2024 - 2033
Fig. 37 U.S. multiomics by cell biology market, 2021 - 2033 (USD Million)
Fig. 38 U.S. multiomics by oncology market, 2021 - 2033 (USD Million)
Fig. 39 U.S. multiomics by neurology market, 2021 - 2033 (USD Million)
Fig. 40 U.S. multiomics by immunology market, 2021 - 2033 (USD Million)
Fig. 41 U.S. Multiomics market: End use outlook and key takeaways
Fig. 42 U.S. Multiomics market: End use market share analysis, 2024 - 2033
Fig. 43 U.S. multiomics by academic and research institutes market, 2021 - 2033 (USD Million)
Fig. 44 U.S. multiomics by pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
Fig. 45 U.S. multiomics by others market, 2021 - 2033 (USD Million)
Fig. 46 Key company categorization
Fig. 47 Company market positioning
Fig. 48 Market participant categorization
Fig. 49 Strategy framework